Telix Pharmaceuticals Limited Sued for Securities Law Violations – Contact the DJS Law Group to Discuss Your Rights – TLX
The DJS Law Group reminds investors of a class action lawsuit against Telix Pharmaceuticals Limited (“Telix” or “the Company”) (NASDAQ: TLX ) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Shareholders who purchased shares of TLX during the […]